KELSEY SMITH: Open Payments
NPI 1386083210 · THOMASVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 11 payments from 8 companies in 2025. Trend: 2023 $61 · 2024 $228 · 2025 $470
Food & beverage: $371Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $138 |
| Amgen Inc. | 1 | $114 |
| Daiichi Sankyo Inc. | 1 | $97 |
| Genentech USA, Inc. | 2 | $38 |
| Stemline Therapeutics Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: KRYSTEXXA, Enhertu, JAKAFI, Orserdu, VERZENIO, Venclexta, FRUZAQLA, Tecentriq Hybreza.
Industry payments across NC — which companies pay providers there.
